Irvine, Calif., May 12, 2009 The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded UC Irvine $45 million over five years for infectious disease research.
The renewal grant, which is the campus's largest ever, went to the Pacific-Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research and its director, Dr. Alan Barbour, a UCI infectious disease expert. Created in May 2005 with a four-year, $40 million NIAID grant, the center and is one of only 11 federally funded research sites dedicated to countering threats from bioterrorism agents and emerging infections.
Pacific-Southwest researchers are located at UCI and 19 other universities and institutes in California, Arizona, Nevada and Hawaii. These include UCLA, USC and the City of Hope.
"Our center brings together some of the region's best scientists to cooperate in research teams. Each person brings a special expertise. Our common goal is prevention and cure of illness by some of the most serious pathogens facing people in the U.S., Latin America and Pacific Rim countries," Barbour said. "We appreciate the new vote of confidence by the National Institutes of Health."
The center's main objective, he said, is to provide the science for creating a defense against emerging diseases, like dengue fever, and potential bioterrorism agents, like the botulism toxin. It also seeks to train next-generation scientists and educate researchers about lab safety.
"While basic research on these infections and immunity to them is at the core of the center, we recognize the importance of the timely translation of our findings into products and other applications that people can actually use," Barbour said. "We've made considerable progress, and we're ready to keep moving ahead."
With the grant, center researchers will continue work on and start new efforts for:
|Contact: Tom Vasich|
University of California - Irvine